These results, together with the recent identification of the ubiquitin E3 ligase cereblon as the target for immunomodulatory drugs such as thalidomide that also are highly active against MM [34, 35], demonstrate that the ubiquitination status of target proteins also has an important role in the pathogenesis of myeloma. The gene discussed is CRBN; the disease is plasma cell myeloma.